Fmoc-(D)Asp(Me)-(N-NHBoc)Ala-NHiBu (9).
Yield over 2 steps = 66%; 1 H NMR (400 MHz, CDCl 3 , mixture of rotamers) δ 8.19 (bs, 0.3H), 7.76 (d, J = 7.5 Hz, 2H), 7.56 (d, J = 7.4 Hz, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.31 (t, J = 7.4 Hz, 2H), 6.61 (bs, 0.3H), 5.85 and 5.42 (2m, 1H), 5.12 -5.01 (m, 1H), 4.87 (d, J = 7.4 Hz, 0.6H), 4.69 (d, J = 7.5 Hz, 0.4H), 4.33 (d, J = 7.9 Hz, 2H), 4.21 (m, 1H), 3.70 and 3.68 (2s, 3H), 3.11 -2.67 (m, 4H), 1.74 (m, 1H), 1.48 (s, 9H), 1.41 (d, J = 7.2 Hz, 3H), 0.84 (m, 6H); 13 C NMR (101 MHz, CDCl 3 ) δ 174. 2, 173.7, 172.0, 171.1, 170.7, 170.3, 156.2, 155.4, 155.0, 143.6, 141.2, 127.81, 127.66, 127.1, 125.1, 125.0, 120.0, 120.0, 83.4, 82.5, 67.5, 67.2, 58.9, 58.8, 52.3, 52.1, 52.0, 48.2, 48.0, 47.0, 38.4, 36.2, 28.3, 28.0, 20.1, 20.0,f 14.6, 13.3 Solution-phase synthesis of tpd dipeptide amides. The dipeptide amides above were treated with 2-5 mL of 4N HCl/dioxane and stirred at rt for 5 h. After removing volatiles under vacuum, the residue was taken up in 5 mL of toluene and heated at 100 °C for 3 h. The reaction was cooled to rt and stirred for 12 h. The volatiles were removed under vacuum and the residue purified by silica gel flash chromatography (CHCl 3 /MeOH) to give the product as an off white solid. 4, 168.0, 166.6, 155.9, 143.7, 143.5, 141.2, 127.8, 127.1, 125.0, 120.0, 67.3, 52.7, 48.0, 47.0, 34.5, 15.0 Fmoc-tpd-Phe-NHiBu (11). Yield over 2 steps = 80%; 1 H NMR (400 MHz, CDCl 3 ) δ 7.75 (d, J = 7.5 Hz, 2H), 7.57 (d, J = 7.4 Hz, 2H), 7.39 (t, J = 7.5 Hz, 2H), 7.35 -7.23 (m, 5H), 7.20 (d, J = 7.3 Hz, 2H), 6.18 (t, J = 5.7 Hz, 1H), 5.53 (m, 2H), 4.46 (m, 1H), 4.37 (d, J = 7.3 Hz, 2H), 4.17 (t, J = 6.9 Hz, 1H), 3.30 -3.15 (m, 2H), 3.10 (dt, J = 13.4, 6.6 Hz, 1H), 3.06 -2.95 (m, 1H), 2.73 (dd, J = 15.4, 4.6 Hz, 1H), 1.80 -1.65 (m, 1H), 1.35 -1.22 (m, 1H), 0.89 -0.84 (m, 6H); 13 C NMR (101 MHz, CDCl 3 ) δ 169. 8, 167.2, 166.4, 155.6, 143.6, 141.3, 134.6, 129.2, 128.9, 127.8, 127.6, 127.1, 125.0, 120.0, 67.2, 56.7, 48.0, 47.0, 47.0, 35.9, 34.4, 28.3, 20.0, 19.9; Fmoc-tpd-Ala-NHiBu (12). Yield over 2 steps = 90%; 1 H NMR (400 MHz, CDCl 3 ) δ 7.76 (d, J = 7.5 Hz, 2H), 7.60 (d, J = 6.4 Hz, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.31 (td, J = 7.5, 0.9 Hz, 2H), 6.14 (t, J = 5.9 Hz, 1H), 5.79 (d, J = 5.4 Hz, 1H), 5.25 (m, 1H), 4.59 (d, J = 13.9 Hz, 1H), 4.42 (d, J = 4.8 Hz, 2H), 4.22 (t, J = 6.9 Hz, 1H), 3.17 -2.95 (m, 3H), 2.57 -2.40 (m, 1H), 1.83 -1.70 (m, 1H), 1.48 (d, J = 7.0 Hz, 3H), 0.90 (d, J = 6.7 Hz, 6H); 13 C NMR (101 MHz, CDCl 3 ) δ 170. 7, 167.0, 165.9, 155.7, 143.7, 143.6, 141.3, 127.8, 127.1, 125.1, 120.2, 67.3, 67.1, 52.3, 48.0, 47.1, 46.9, 34.9, 29.7, 28.3, 20.0, 19.9 Kang et al. allowed to swell in DMF for 2 h prior to use. All reactions were carried out using gentle agitation. Fmoc deprotection steps were carried out by treating the resin with a solution of 20% piperidine/DMF at 50 o C (15 min x 2). Coupling of Fmoc-protected amino acids as well as (N'-Boc)-hydrazino acids was effected using 5 equiv. HATU (0.5 M in DMF), 10 equiv. DIEA (1.0 M in DMF), and 5 equiv. of the carboxylic acid in 5:1 DMF:DCM at 50 o C (1 h x 2). Coupling of the D-Asp subunit to the resin-bound Bochydrazine was carried out with 9 equiv. collidine and 3 equiv. of Fmoc-D-Asp(Me)-Cl 1 in THF at 50 o C (1 h x 3). Acetylation of the peptide N-terminus was carried out using 10 equiv. of Ac 2 O and 20 equiv. of pyridine in DCM at rt (1 h x 2). After each reaction the resin was washed with DMF 3x, DCM 2x, then DMF 1x. Prior to cleavage, the resin was washed with MeOH 5x and dried thoroughly under vacuum. Compounds were cleaved by incubating the dried resin in 2 mL of 95:5 TFA:H 2 O at rt for 4 h. The cleavage mixture was filtered and the resin was rinsed with an additional 1 mL of cleavage solution. The filtrate was concentrated to remove the bulk of the TFA and the remaining residue was treated with 8 mL of cold Et 2 O to induce precipitation. The mixture was centrifuged and the supernatant was removed. The remaining solid was washed 2 more times with Et 2 O and dried under vacuum. The crude peptides were purified by RP-HPLC on a C8 semi-preparative column using linear gradients of MeCN in 0.1% aq. formic acid, then lyophilized to afford white powders. All peptides were characterized by LCMS (ESI), HRMS (ESI-TOF), and 1 H NMR. 
Fmoc-tpd-Ala-NH 2 (10)
.
Ac-tpd-

H-Leu-tpd-Leu-tpd-Leu-Glu-NH 2 (17)
. Overall yield = 13%; 1 H NMR (400 MHz, DMSO-d 6 ) δ 8.65 (
QUANTUM MECHANICS CALUCULATIONS
All quantum calculations were performed with the Jaguar 2,3 quantum chemistry program from Schrödinger, Inc. Ramachandran-type energy surfaces of  2 vs ψ 2 dihedral angles were generated by combinatorialy fixing  and ψ angles (Figure 2 ) at every 15° from 0° to 360°. No other constraints were imposed. The ω angle for all molecules was constructed in a trans configuration for all simulations. A relaxed coordinate scan was performed with geometry optimization and energy calculations determined at the M06-2X-D3/6-31G* level 4 with the SM6 implicit solvent model 5 .
X-RAY DIFFRACTION ANALYSIS
The X-ray diffraction data for 10 and 11 were measured on a Bruker D8 Venture PHOTON 100 CMOS system equipped with a Cu Kα INCOATEC Imus micro-focus source (λ = 1.54178 Å). Indexing was performed using APEX2 6 (Difference Vectors method). Data integration and reduction were performed using SaintPlus 6.01. 7 Absorption correction was performed by multi-scan method implemented in SADABS 8 . Space groups were determined using XPREP implemented in APEX2 6 . The structure was solved using SHELXS-97 (direct methods) and refined using SHELXL-2013 9 (full-matrix least-squares on F2) contained in APEX2 6,9 , WinGX v1.70.01 9, 10, 11, 12 and OLEX2 9, 13 . Part of the molecule is disordered over two positions with 0.84:0.16 occupancy ratio (refined as FVAR 2/-2). Non-disordered atoms and those in major part of the disorder were refined anisotropically and atoms with low occupancy were refined isotropically and with geometry and isotropic displacement parameters restraints. Hydrogen atoms of -NH groups have been found from difference Fourier map and were refined freely or with Uiso(H) = 1.2Ueq(-NH). Hydrogen atoms of -CH, -CH2 and -CH3 groups were placed in geometrically calculated positions and included in the refinement process using riding model with isotropic thermal parameters: Uiso(H) = 1.2(1.5)Ueq(-CH,-CH2(-CH3)). The contents of asymmetric units (with the exception of minor part of disorder) has been shown on Figs.1 and 2. Crystal data and refinement conditions are shown in Tables 1 and 2 . 
